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It has long been recognized that prolongation of the QRS
complex in the surface electrocardiogram is an independent
predictor of an adverse outcome in patients with heart
failure (HF) (1,2). In most patients with dilated cardiomy-
opathy, QRS prolongation presents as a left bundle branch
block (LBBB) (3,4). Not only is LBBB a marker of disease
progression in cardiomyopathy but the ventricular dyssyn-
chrony associated with ventricular conduction delay may
have negative hemodynamic consequences: it can reduce
contractility (5) and ejection fraction (6), shorten diastolic
filling time (7), and cause functional mitral regurgitation
(8). Thus, ventricular conduction disturbance in HF may
lead to a vicious circle with further hemodynamic deterio-
ration and left ventricular (LV) dilation. There is experi-
mental evidence that asynchronous LV activation results in
a reduced work in early-activated regions (i.e., the septum in
LBBB) and increased work in late-activated regions (i.e.,
the LV free wall) (9) which causes asymmetric LV hyper-
trophy (10). This may be explained on the basis of regional
disparities in the expression of calcium handling and stress
proteins (11).
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The prognostic implications of increased interventricular
and intraventricular dyssynchrony in HF patients with
prolonged QRS complex are yet unclear. In this issue of the
Journal, Fauchier et al. (12) analyzed the prognostic impor-
tance of LV intraventricular versus interventricular dyssyn-
chrony as analyzed by radionuclide scintigraphy in patients
with nonischemic cardiomyopathy. The main finding was
that increased LV intraventricular dyssynchrony was pre-
dictive of major cardiac events, as defined by cardiac death
or worsening of HF leading to heart transplantation, but not
interventricular dyssynchrony. However, the risk of a major
cardiac event was only mildly elevated for patients with
increased intraventricular dyssynchrony as indicated by a
hazard ratio of only 1.021.
The evaluation of the pathophysiologic consequences of
cardiac conduction disturbances, such as LBBB, is an
interesting new application for cardiac nuclear imaging.
Beyond functional assessment of interventricular and intra-
ventricular dyssynchrony by Fourier phase analysis of equi-
librium radionuclide angiography as performed by Fauchier
et al. (12), nuclear imaging techniques have also been used
to study the effects of LBBB on myocardial perfusion and
metabolism. A reduction in septal glucose uptake with
preserved myocardial blood flow (13) has been noted in
LBBB caused by dilated cardiomyopathy, whereas there is
ongoing discussion on the effects on oxidative metabolism
(14,15). Cardiac resynchronization therapy (CRT), which
aims to correct the hemodynamic disturbances caused by
ventricular dyssynchrony in patients with moderate-to-
advanced HF and LBBB, has been shown to have some
positive impact on the metabolic effects of ventricular
dyssynchrony. Preliminary data suggest improved myocar-
dial oxygen consumption during low-dose dobutamine
stress with biventricular (BV) pacing as determined by
11C-acetate positron emission tomography (16) and a res-
toration of a homogeneous myocardial glucose metabolism
as shown by 18F-fluorodeoxyglucose positron emission to-
mography (17).
Acute hemodynamic (18–20) and mid-term functional
improvement (21–23) as well as a reverse remodeling effect
(24–27) have been demonstrated with CRT. Cardiac re-
synchronization is usually achieved by atrial triggered BV
pacing, but it is unclear whether BV pacing is necessary to
achieve optimal ventricular resynchronization or whether it
is sufficient to pace only the LV. Currently available
evidence suggests that there is no clear advantage of BV over
LV pacing, but most studies are limited by small sample
sizes (22), nonrandomized study design (28), or no direct
comparison of both approaches (29). The real question
behind this debate is whether it is necessary to achieve
interventricular synchronization or whether it is sufficient to
correct LV intraventricular dyssynchrony. Parameters of
interventricular dyssynchrony such as the interventricular
mechanical delay derived from echocardiography are being
used to identify patients suitable for CRT, based on the
assumption that correction of interventricular dyssynchrony
may be an adequate therapeutic target (30). The data from
the study by Fauchier et al. (12) do not support this
hypothesis because interventricular dyssynchrony did not
prove to be of prognostic importance. In contrast, increased
LV intraventricular dyssynchrony is not only relevant for
prognosis but has also been shown to predict a positive
response to CRT (31,32). If only the LV has to be
resynchronized, one may speculate that LV pacing alone,
with a critically timed atrioventricular delay allowing fusion
with intrinsic conduction through the right bundle branch,
is enough to achieve optimal hemodynamic support in HF
patients with LBBB.
However, the argument that interventricular delay has
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some importance cannot be easily refuted. First, correction
of interventricular dyssynchrony may still lead to hemody-
namic improvement despite a lack of prognostic impor-
tance. A scintigraphic study by Kerwin et al. (33) using
similar methodology as in the study presented in this issue
of the Journal indicated that BV pacing mainly reduced
interventricular but actually increased LV intraventricular
dyssynchrony. However, these data were confounded by a
heterogeneous patient population studied, including pa-
tients with right bundle branch block, ischemic heart
disease, and only minor conduction delay. Moreover, LV
lead position was not standardized, which is a critical
determinant of therapeutic success in CRT. It is now
accepted that a lateral or posterior LV lead position, i.e., in
the area of the LV that is usually activated with the greatest
delay in LBBB, provides optimal ventricular resynchroniza-
tion and, thus, hemodynamic support (34).
Second, the positive hemodynamic impact of correcting
LV intraventricular dyssynchrony by CRT may not neces-
sarily translate into improvement in prognosis. Previous
studies with positive inotropic drugs (35–37) have taught us
to be cautious with assumptions on prognosis in therapeutic
interventions that acutely improve cardiac hemodynamics.
However, there is good reason to be optimistic that the
hemodynamic benefit achieved by CRT may not be paid for
by increased mortality because CRT does not seem to
increase myocardial oxygen demand as opposed to positive
inotropic drugs (38).
Third, another aspect of the study by Fauchier et al. (12)
deserves our attention: there may be a potential hazard of
right ventricular (RV) desynchronization caused by CRT as
RV intraventricular dyssynchrony was found to be predictive
of an adverse outcome at least by univariate analysis; LV
pacing alone especially may lead to substantial RV desyn-
chronization. This may not only impair RV hemodynamic
performance (39) and promote the occurrence of right-sided
HF but may also potentially have a negative prognostic
impact. This could be an advantage of BV over LV
resynchronization because it does not appear to increase RV
dyssynchrony substantially (33). However, in animal studies
even BV pacing has been shown to impair RV hemodynam-
ics acutely (40). Moreover, there are only very few long-term
data with CRT and no data on RV function after long-term
LV or BV pacing to the best of our knowledge.
Currently, there are no prospective data available on the
influence of CRT on mortality in patients with HF. Thus,
any discussion about the prognostic impact of interventric-
ular versus intraventricular resynchronization remains spec-
ulative. Hopefully, the ongoing COMPANION study (41),
which analyzes all-cause mortality as the primary study end
point, and the CARE-HF (30) study, investigating the
combined end point of all-cause mortality and unplanned
cardiovascular hospitalizations, will answer the question of
whether CRT has a positive impact on these significant
clinical end points. However, both studies only apply BV
pacing and, therefore, the question of whether correction of
interventricular dyssynchrony is necessary will not be an-
swered.
Caution needs to be taken when interpreting the data
presented by Fauchier et al. (12) on the correlation of
intraventricular and interventricular dyssynchrony to hemo-
dynamic parameters. Intraventricular dyssynchrony in both
ventricles appeared to correlate to echocardiographic mea-
surements of LV function (end-diastolic and end-systolic
diameter, ejection fraction) and to cardiac index, whereas
only RV dyssynchrony correlated to functional parameters
(New York Heart Association [NYHA] functional class,
peak oxygen consumption) and RV ejection fraction. Even
more surprising, interventricular delay showed an inverse
correlation to NYHA functional class, i.e., less interventric-
ular dyssynchrony was associated with functional impair-
ment. It is likely that echocardiograms and radionuclide
scans were not taken on the same day and the correlations
were confounded by differences in volume status of the
patients. No data on drug treatment are provided, which
further limits the relevance of the observed correlations. In
addition, the assessment of NYHA functional class may be
too imprecise to allow for a meaningful correlation with the
scintigraphic data. Nevertheless, the data should at least
raise our attention to the potential importance of RV
dyssynchrony in patients with HF, which has frequently
been neglected in the discussion on CRT.
Clearly, more questions are raised than answers provided
by the data from the Fauchier et al. (12) study. However,
the study sheds some light on the importance of ventricular
conduction disturbance in a relevant number of patients
with dilated cardiomyopathy, and the authors should be
credited for this effort. At present, we can only conclude
that for patients suffering from systolic HF it is obviously of
prognostic important that LV contraction is in synchrony.
There is great hope that CRT may therefore improve
prognosis in HF patients with ventricular conduction delay.
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